Literature DB >> 26157576

The regulation of osteoclast differentiation by Wnt signals.

Yasuhiro Kobayashi1, Shunsuke Uehara2, Masanori Koide1, Naoyuki Takahashi1.   

Abstract

Wnt ligands activate β-catenin-dependent canonical and -independent noncanonical signaling pathways. Wnt regulates many physiological events such as the development of organs and bone metabolism. In contrast, failed signaling leads to pathological conditions including cancer and osteoporosis. Analyses of loss-of-function mutations in the low-density lipoprotein receptor-related protein (Lrp) 5 gene revealed that Lrp5 acted as a co-receptor of Wnt/β-catenin signals and positively regulated bone mass in humans and mice. Many players in Wnt signals including sclerostin, an osteocyte-derived Wnt antagonist, also have since been found to influence bone mass. Bone mass is regulated by the activities of bone-forming osteoblasts, -resorbing osteoclasts and matrix-embedded osteocytes. The roles of Wnt/β-catenin signals in osteoblastogenesis and osteoclastogenesis have been established by the findings of a large number of in vitro and in vivo studies. In contrast, the roles of noncanonical Wnt signals in bone metabolism are only now being examined. In this review, we introduced and discussed recent information on the roles of Wnt signals in bone resorption.

Entities:  

Year:  2015        PMID: 26157576      PMCID: PMC4495780          DOI: 10.1038/bonekey.2015.82

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  46 in total

1.  Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes.

Authors:  Lige Song; Minlin Liu; Noriaki Ono; F Richard Bringhurst; Henry M Kronenberg; Jun Guo
Journal:  J Bone Miner Res       Date:  2012-11       Impact factor: 6.741

2.  Wnt signaling regulates hemopoiesis through stromal cells.

Authors:  T Yamane; T Kunisada; H Tsukamoto; H Yamazaki; H Niwa; S Takada; S I Hayashi
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

Review 4.  Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.

Authors:  Michael D Gordon; Roel Nusse
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

5.  Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.

Authors:  Ming-Kang Chang; Ina Kramer; Thomas Huber; Bernd Kinzel; Sabine Guth-Gundel; Olivier Leupin; Michaela Kneissel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 6.  Regulation of bone mass by Wnt signaling.

Authors:  Venkatesh Krishnan; Henry U Bryant; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.

Authors:  Isao Oishi; Hiroaki Suzuki; Nobuyuki Onishi; Ritsuko Takada; Shuichi Kani; Bisei Ohkawara; Ikue Koshida; Kentaro Suzuki; General Yamada; Georg C Schwabe; Stefan Mundlos; Hiroshi Shibuya; Shinji Takada; Yasuhiro Minami
Journal:  Genes Cells       Date:  2003-07       Impact factor: 1.891

8.  Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway.

Authors:  Alexandra Schambony; Doris Wedlich
Journal:  Dev Cell       Date:  2007-05       Impact factor: 12.270

9.  Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.

Authors:  Tohru Ishitani; Jun Ninomiya-Tsuji; Kunihiro Matsumoto
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

10.  Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.

Authors:  Hong Y Choi; Marco Dieckmann; Joachim Herz; Andreas Niemeier
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more
  17 in total

1.  Polymorphisms of the WNT16 gene are associated with the heel ultrasound parameter in young adults.

Authors:  M Correa-Rodríguez; J Schmidt Rio-Valle; B Rueda-Medina
Journal:  Osteoporos Int       Date:  2015-10-28       Impact factor: 4.507

2.  Defective signaling, osteoblastogenesis and bone remodeling in a mouse model of connexin 43 C-terminal truncation.

Authors:  Megan C Moorer; Carla Hebert; Ryan E Tomlinson; Shama R Iyer; Max Chason; Joseph P Stains
Journal:  J Cell Sci       Date:  2017-01-03       Impact factor: 5.285

Review 3.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

4.  Regulation of Bone Metabolism.

Authors:  Maryam Shahi; Amir Peymani; Mehdi Sahmani
Journal:  Rep Biochem Mol Biol       Date:  2017-04

5.  Circulating DNA and its methylation level in inflammatory bowel disease and related colon cancer.

Authors:  Xuming Bai; Yaqun Zhu; Wangyang Pu; Li Xiao; Kai Li; Chungen Xing; Yong Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis.

Authors:  Shasha He; Qian Zhou; Binyan Luo; Bin Chen; Lingjun Li; Fuhua Yan
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

7.  Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women.

Authors:  Yukio Nakamura; Takako Suzuki; Mikio Kamimura; Shota Ikegami; Kohei Murakami; Shigeharu Uchiyama; Akira Taguchi; Hiroyuki Kato
Journal:  Bone Res       Date:  2017-06-13       Impact factor: 13.567

8.  Cytoplasmic PCNA is located in the actin belt and involved in osteoclast differentiation.

Authors:  Donge Tang; Xiaohui Liu; Kezhi Chen; Zhipeng Li; Yong Dai; Jiake Xu; Huan-Tian Zhang; Xuejuan Gao; Langxia Liu
Journal:  Aging (Albany NY)       Date:  2020-06-27       Impact factor: 5.682

9.  Aminothiazoles inhibit osteoclastogenesis and PGE2 production in LPS-stimulated co-cultures of periodontal ligament and RAW 264.7 cells, and RANKL-mediated osteoclastogenesis and bone resorption in PBMCs.

Authors:  Anna Kats; Natalija Gerasimcik; Tuomas Näreoja; Jonas Nederberg; Simon Grenlöv; Ekaterina Lagnöhed; Suchita Desai; Göran Andersson; Tülay Yucel-Lindberg
Journal:  J Cell Mol Med       Date:  2018-12-01       Impact factor: 5.310

Review 10.  V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.

Authors:  Xiaohong Duan; Shaoqing Yang; Lei Zhang; Tielin Yang
Journal:  Theranostics       Date:  2018-10-26       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.